• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing
The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine
Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments
Ibogaine's Momentum Is Real. So Is the Safety Gap Nobody's Solving.
Psychedelic Medicine Is Having an Identity Crisis — And That's a Good Thing
Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won't Get You High
FDA's New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn't Fully Realized It Yet
Medical Psilocybin Act
PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field
Shop

Bill To Legalize Psychedelics Passes California Senate

Microdose NewsDesk by Microdose NewsDesk
May 25, 2023
in Law & Politics
Reading Time: 1 min read
A A
Bill To Legalize Psychedelics Passes California Senate

The California Senate has passed a bill legalizing the possession of natural psychedelics.

Sen. Scott Wiener (D) has been pushing psychedelics bills for years, and has finally succeeded in passing this latest bill through the Senate. This latest bill was approved with a 21-16 vote yesterday and will head to the General Assembly for debate.

SB 58 legalizes specific amounts of psilocybin, psilocyn, DMT, ibogaine and mescaline. This would be for personal or facilitated use and the “possession, preparation, obtaining, transfer, as specified, or transportation…”.

The major difference between this bill and previous attempts was the exclusion of synthetic substances. Psychedelics like LSD and MDMA were not included, with a focus on natural plant entheogens making it more likely to pass the Senate.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

The bill allows the following limits on psychedelic possession:

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

 

Read the full bill here

Lasix Meds For Sale

and see comments from Rep Scott Weiner below.

 

The Senate just passed our bill (SB 58) to decriminalize possession & use of 5 naturally occurring psychedelics — psilocybin, psilocin, DMT, ibogaine, mescaline.

These substances aren’t addictive & show promise in treating mental health /addiction. Let’s stop criminalizing them.

— Senator Scott Wiener (@Scott_Wiener) May 24, 2023

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
MindMed Publishes Report by FDA Experts: Is FCM’s Takeover Attempt Over?

MindMed Publishes Report by FDA Experts: Is FCM's Takeover Attempt Over?

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.